Suchergebnisse - "Bates, Timothy A"

PubPharm (8)

1

Evaluating Humoral Immunity Elicited by XBB.1.5 Monovalent COVID-19 Vaccine

enthalten in: Emerging infectious diseases | 2024

von Nguyenla, X. | Bates, T. | Trank-Greene, M. | +3

2

An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants

enthalten in: JCI insight | 2023

von Bates, T. | Leier, H. | McBride, S. | +6

UpdateOf: medRxiv. 2023 Jan 04;:. - PMID 36656773

3

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection

enthalten in: Med (New York, N.Y.) | 2022

von Curlin, M. | Bates, T. | Guzman, G. | +4

UpdateOf: medRxiv. 2022 Apr 12;:. - PMID 35441177

4

BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age

enthalten in: Cell reports | 2022

von Bates, T. | Lu, P. | Kang, Y. | +9

UpdateOf: medRxiv. 2022 Aug 16;:. - PMID 36032979

5

High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers

enthalten in: BMC infectious diseases | 2022

von Gelanew, T. | Seyoum, B. | Mulu, A. | +27

UpdateOf: Res Sq. 2021 Jul 19;:. - PMID 34312618

6

High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers

enthalten in: BMC infectious diseases | 2022

von Gelanew, T. | Seyoum, B. | Mulu, A. | +27

7

High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers

enthalten in: BMC infectious diseases | 2022

von Gelanew, T. | Seyoum, B. | Mulu, A. | +27

8

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2

enthalten in: Cell reports | 2021

von Bates, T. | Weinstein, J. | Farley, S. | +3

UpdateOf: bioRxiv. 2020 Jul 30;:. - PMID 32766589

1
[1]